sovaldi | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sovaldi
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

sovaldi

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 10 USDMF, 9 EU WC, 3 KDMF, 7 NDC API, 26 Listed Suppliers, $ API Reference Price

36 API Suppliers
10 USDMF
9 EU WC
3 KDMF
7 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

16 Intermediates Suppliers

16 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers, 14 FDA Orange Book, 6 Europe, 4 Canada, 2 South Africa, 15 Listed Dossiers

41 FDF Dossiers
14 FDA Orange Book
6 Europe
4 Canada
2 South Africa
15 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 2 Seqens, 4 DKSH, 1 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 3 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 22 Kerry, 12 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 31 Direct Compression, 21 Coating Systems & Additives, 16 Granulation, 16 Thickeners and Stabilizers, 15 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 14 Co-Processed Excipients, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 9 Topical, 9 Parenteral, 9 Film Formers & Plasticizers, 6 Solubilizers, 3 Coloring Agents, 3 Emulsifying Agents, 3 API Stability Enhancers, 2 Rheology Modifiers

65 Fillers, Diluents & Binders
31 Direct Compression
21 Coating Systems & Additives
16 Granulation
16 Thickeners and Stabilizers
15 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
14 Lubricants & Glidants
14 Co-Processed Excipients
12 Taste Masking
11 Chewable & Orodispersible Aids
9 Topical
9 Parenteral
9 Film Formers & Plasticizers
6 Solubilizers
3 Coloring Agents
3 Emulsifying Agents
3 API Stability Enhancers
2 Rheology Modifiers

DIGITAL CONTENT

22 DATA COMPILATION #PharmaFlow, 272 NEWS #PharmaBuzz

22 DATA COMPILATION #PharmaFlow
272 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 7 Finished Drug Prices, 15 Annual Reports

2 US Medicaid Prescriptions
7 Finished Drug Prices
15 Annual Reports

MARKET PLACE

19 APIs, 1 FDF Dossiers

19 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

358 US Patents, 44 US Exclusivities, 2 Health Canada Patents

358 US Patents
44 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 730 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

44 All

01 44GILEAD SCIENCES INC

filter Product Reset all filters

44 All

01 12LEDIPASVIR; SOFOSBUVIR

02 12SOFOSBUVIR

03 20SOFOSBUVIR; VELPATASVIR

filter Exclusivity Expiration Date Reset all filters

44 All

01 22023-07-14

02 22024-01-14

03 62024-04-07

04 62024-10-07

05 42025-04-27

06 122026-08-28

07 22027-03-19

08 22027-09-19

09 42028-06-10

10 42028-12-10

filter Exclusivity Code Reset all filters

44 All

01 2M-264

02 4M-277

03 8ODE*

04 1ODE-135

05 1ODE-136

06 2ODE-258

07 2ODE-262

08 2ODE-263

09 2ODE-264

10 2ODE-293

11 4ODE-376

12 14PED

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2024-04-07

Application Number

205834

Product Number

2

Exclusivity Details

01

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2024-04-07

Application Number : 205834

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

205834

Product Number

2

Exclusivity Details

02

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 205834

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

205834

Product Number

1

Exclusivity Details

03

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 205834

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-264

Exclusivity Expiration Date

2023-07-14

Application Number

208341

Product Number

1

Exclusivity Details

04

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-264

Exclusivity Expiration Date : 2023-07-14

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEDIPASVIR; SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-136

Exclusivity Expiration Date

2024-04-07

Application Number

205834

Product Number

1

Exclusivity Details

05

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEDIPASVIR; SOFOSBUVIR

Exclusivity Code : ODE-136

Exclusivity Expiration Date : 2024-04-07

Application Number : 205834

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

1

Exclusivity Details

06

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

204671

Product Number

2

Exclusivity Details

07

GILEAD SCIENCES INC

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 204671

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2024-04-07

Application Number

204671

Product Number

2

Exclusivity Details

08

GILEAD SCIENCES INC

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2024-04-07

Application Number : 204671

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE*

Exclusivity Expiration Date

2026-08-28

Application Number

204671

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE*

Exclusivity Expiration Date : 2026-08-28

Application Number : 204671

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-135

Exclusivity Expiration Date

2024-04-07

Application Number

204671

Product Number

1

Exclusivity Details

10

GILEAD SCIENCES INC

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-135

Exclusivity Expiration Date : 2024-04-07

Application Number : 204671

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?